medigraphic.com
Medicina Universitaria

2007, Number 37

<< Back Next >>

Med Univer 2007; 9 (37)

Non-albicans Candida species in the ginecological consultation

Iglesias BJL, Saldívar RD, Tijerina MR, González GG, Garza GE, Rosales TE

Language: Spanish
References: 19
Page: 161-165
PDF size: 100.68 Kb.


ABSTRACT

Introduction: Candida albicans is considered the most common fungi associated to vaginitis, but other Candida species have been documented. The objective is looking for the incidence of species of non-albicans Candida in the gynecology consultation.
Objective: Know the prevalence of Candida non albicans species in the gynecological consultation.
Material and methods: 250 patients were included and divided into three groups: 100 women with vaginitis symptoms; 100 asymptomatic and 50 women evaluated for infertility. We obtained two samples, from the uterine cervix and the vaginal wall, for Candida identification. Candida was isolated in Sabouraud medium. The identification of the species was made with substrate reaction analysis API 20 C AUX (bioMerieux). Statistical analysis was done by chi square.
Results: Of 24 positive cases in the symptomatic group, 18 were of glabrata sp. and 6 were Albicans sp. We found 21 positive cases of Candida in the asymptomatic women; 10 corresponded to C. albicans; 9 to C. glabrata; 1 C. famata and 1 C. tropicalis. There were 13 positive cases of Candida in the group of infertile patients; 6 were of C. albicans, 6 of C. glabrata and 1 C. tropicalis. In the first two groups we found 73 patients with repetitive vulvovaginitis, in these patients we found 22 positive cases for Candida; 5 were C albicans and 17 were C. glabrata (P‹0.001). The KOH test was positive in 27 cases (46.1%).
Conclusions: C. glabrata was the most common Candida species in patients with symptomatic and recurrent vaginitis.


REFERENCES

  1. Bonifaz A. Micología médica básica. 2Ş ed. México: Méndez editores, 2002;pp:301-27.

  2. Horowitz BJ. Mycotic vulvovaginitis: a broad overview. Am J Obstet Gynecol 1991;165:1188-92.

  3. Nguyen MH, Peacock JE, Morris AJ, Tanner DC, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 1996;100:617-23.

  4. Fidel PL, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to Candida albicans. Clin Microbiol Rev 1999;12:80-96.

  5. Sobel JD, Faro S, Force RW, Foxman B, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-11.

  6. Spinillo A, Capuzzo E, Egbe TO, Incola S, Piáis G. Torulopsis glabrata vaginitis. Obstet Gynecol 1995;85:993-8.

  7. Lynch ME, Sobel JD, Fidel PL. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis. J Med Vet Mycol 1996;34:337-9.

  8. Rogers TJ, Balish E. Immunity to Candida albicans. Microbiol Rev 1980;44:660-82.

  9. Fidel PL, Lynch ME, Sobel JD. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun 1993;61:1990-5.

  10. Sangeorzan JA, Bradley SF, He X, Zarins LT, et al. Epidemiology of oral candidiasis in HIV infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994;97:339-46.

  11. Mathur S, Koistinen GV, Horger EO, Mahvi TA, Fundenberg HH. Humoral immunity in vaginal candidiasis. Infect Immun 1977;15:287-94 .

  12. Mendling W, Koldovsky U. Immunological investigations in vaginal mycoses. Mycoses1996;39:177-83.

  13. Geiger AM, Foxman B, Sobel JD. Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no Candida. Genitourin Med 1995;71:304-7.

  14. Ferris DG, Nyirjesy P, Sobel JD, Soper D, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002;99:419-25.

  15. Fox R, Neal KR, Leen CL, Ellis ME, Mandal BK. Fluconazole resistant Candida in AIDS. J Infect 1991;22:201-4.

  16. Wingard JR, Merz WG, Rinaldi MG, Millar CB, et al. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 1993;37:1847-9.

  17. Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW. Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemoter 1993;37:1962-5.

  18. Warnock DW, Burke J, Cope NJ, Jonhson EM, et al. Fluconazole resistance in Candida glabrata. Lancet 1988;2:1310.

  19. Sobel JD, Chaim W. Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy. Clin Infect Dis 1997;24:649-52.




2020     |     www.medigraphic.com